Zeo ScientifiX (ZEOX) Net Income towards Common Stockholders (2012 - 2026)
Zeo ScientifiX (ZEOX) posted Net Income towards Common Stockholders of -$145,000 for fiscal Q2 2026 (quarter ended Apr 30, 2026), compared with -$1.39 million a year earlier.
Powered by 
Analysis
Zeo ScientifiX (ZEOX) Net Income towards Common Stockholders (2012 - 2026) Analysis & Trends
For the trailing twelve months through Apr 30, 2026, Net Income towards Common Stockholders at Zeo ScientifiX was -$3.88 million; for FY2025 (ended Oct 31, 2025), it came in at -$5.52 million.
- In prior fiscal years, Zeo ScientifiX's Net Income towards Common Stockholders was -$4.71 million in FY2024, -$6.99 million in FY2023, -$8.9 million in FY2022 and -$12.76 million in FY2021.
- The fiscal Q2 2026 figure stands as the highest quarterly Net Income towards Common Stockholders since fiscal Q1 2018.
- According to Business Quant data, Net Income towards Common Stockholders for the three prior fiscal quarters was -$852,000 (Q1 2026), -$815,000 (Q4 2025) and -$2.07 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Zeo ScientifiX | 9.73 Mn | 6.32 Mn | 2.06 Mn | -145,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -145,000.00 |
| Jan 31, 2026 | -852,000.00 |
| Oct 31, 2025 | -815,000.00 |
| Jul 31, 2025 | -2.07 Mn |
| Apr 30, 2025 | -1.39 Mn |
| Jan 31, 2025 | -1.24 Mn |
| Oct 31, 2024 | -1.25 Mn |
| Jul 31, 2024 | -1.01 Mn |
| Apr 30, 2024 | -1.40 Mn |
| Jan 31, 2024 | -1.04 Mn |
| Oct 31, 2023 | -1.09 Mn |
| Jul 31, 2023 | -1.62 Mn |
| Apr 30, 2023 | -1.99 Mn |
| Jan 31, 2023 | -2.29 Mn |
| Oct 31, 2022 | -3.02 Mn |
| Jul 31, 2022 | -2.73 Mn |
| Apr 30, 2022 | -1.46 Mn |
| Jan 31, 2022 | -1.69 Mn |
| Oct 31, 2021 | -958,152.00 |
| Jul 31, 2021 | -1.41 Mn |
API Access
Zeo ScientifiX Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ZEOX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "ZEOX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ZEOX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();